Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Inhibikase Therapeutics Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Inhibikase Therapeutics is forecast to grow earnings and revenue by 35.2% and 80.8% per annum respectively while EPS is expected to grow by 48.1% per annum.
Anahtar bilgiler
35.2%
Kazanç büyüme oranı
48.1%
EPS büyüme oranı
| Biotechs kazanç büyümesi | 28.6% |
| Gelir büyüme oranı | 80.8% |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | Low |
| Son güncelleme | 15 Aug 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Can Inhibikase Therapeutics (NASDAQ:IKT) Afford To Invest In Growth?
Jan 25
Inhibikase stock rises 12% on FDA nod to start study of IkT-001Pro for leukemia
Aug 26Inhibikase Therapeutics GAAP EPS of -$0.18, revenue of $6.55M
Aug 12Will Inhibikase Therapeutics (NASDAQ:IKT) Spend Its Cash Wisely?
Aug 09Here's Why We're Watching Inhibikase Therapeutics' (NASDAQ:IKT) Cash Burn Situation
Apr 06Inhibikase Therapeutics prices stock offering at $3
Jun 16Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 9 | -26 | N/A | -23 | 2 |
| 12/31/2025 | N/A | -27 | N/A | -21 | 2 |
| 12/31/2024 | N/A | -20 | N/A | -19 | 2 |
| 6/30/2024 | 0 | -18 | -16 | -16 | N/A |
| 3/31/2024 | 0 | -19 | -16 | -16 | N/A |
| 12/31/2023 | 0 | -19 | -18 | -18 | N/A |
| 9/30/2023 | 0 | -19 | -18 | -18 | N/A |
| 6/30/2023 | 0 | -19 | -20 | -20 | N/A |
| 3/31/2023 | 0 | -18 | -20 | -19 | N/A |
| 12/31/2022 | 0 | -18 | -18 | -17 | N/A |
| 9/30/2022 | 0 | -19 | -18 | -18 | N/A |
| 6/30/2022 | 0 | -19 | -14 | -14 | N/A |
| 3/31/2022 | 2 | -17 | -14 | -14 | N/A |
| 12/31/2021 | 3 | -15 | -14 | -14 | N/A |
| 9/30/2021 | 3 | -11 | -11 | -11 | N/A |
| 6/30/2021 | 3 | -7 | -9 | -9 | N/A |
| 3/31/2021 | 2 | -5 | -5 | -5 | N/A |
| 12/31/2020 | 1 | -3 | -1 | -1 | N/A |
| 9/30/2020 | 1 | -2 | 0 | 0 | N/A |
| 6/30/2020 | 1 | -3 | 0 | 0 | N/A |
| 3/31/2020 | 1 | -5 | 0 | 0 | N/A |
| 12/31/2019 | 1 | -6 | 0 | 0 | N/A |
| 9/30/2019 | 2 | -7 | 1 | 1 | N/A |
| 3/31/2019 | 4 | -4 | 0 | 0 | N/A |
| 12/31/2018 | 4 | -2 | 1 | 1 | N/A |
| 9/30/2018 | 3 | -1 | 0 | 0 | N/A |
| 3/31/2018 | 3 | 0 | N/A | 0 | N/A |
| 12/31/2017 | 2 | 0 | N/A | 0 | N/A |
| 12/31/2016 | 1 | -1 | N/A | 0 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: IKT is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: IKT is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: IKT is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: IKT is forecast to have no revenue next year.
Yüksek Büyüme Geliri: IKT is forecast to have no revenue next year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if IKT's Return on Equity is forecast to be high in 3 years time